CANC vs PAVE5YCANCCANCAvsBPAVEPAVETema Oncology ETF · $217MGlobal X - U.S. Infrastructure Development ETF · $13.5BReturns · dividends in+23.9%3 years · per year$19,015 · $18,382+22.5%[…]5 years · per year[…] · $19,922+14.8%Cost and income0.99%Expense ratio$99 · $47 on $10k · lower wins0.47%0.05%12-mo yield$5 · $80 on $10k0.80%Risk · 1 year−13.2%End-of-day Nov 11, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
Both5Y2 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BPAVEGlobal X - U.S. Infrastructure Development ETFReadDesk0.47%0.80%+1.3%+13.1%+13.0%+22.5%+14.8%−15.3%$13.5B2ACANCTema Oncology ETFReadDesk0.99%0.05%−0.9%+21.8%+33.2%+23.9%new−13.2%$217MEnd-of-day Nov 11, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
Both5Y2 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BPAVEGlobal X - U.S. Infrastructure Development ETFReadDesk0.47%0.80%+1.3%+13.1%+13.0%+22.5%+14.8%−15.3%$13.5B2ACANCTema Oncology ETFReadDesk0.99%0.05%−0.9%+21.8%+33.2%+23.9%new−13.2%$217MEnd-of-day Nov 11, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
$10,000 in CANC, PAVE5Y$10k startPAVE $19.9kNov 2021Nov 2026End-of-day Nov 11, 2026 · growth of $10,000, dividends reinvested · from each fund’s start inside the window
Overlap: CANC, PAVEToday0.0%most shared, CANC and PAVECANCPAVECANC—0.0%PAVE0.0%—End-of-day Nov 11, 2026 · share held in common · outlined: the pair in versus
CANC vs PAVE5YACANCTema Oncology[…]vsPAVEBGlobal X - U.S. Infrastructure Development$19,922MeasureCANCPAVEFee0.99%0.47%Cost on $10k a year$99$47Yield0.05%0.80%5 years, per year[…]+14.8%3 years, per year+23.9%+22.5%Worst drop · 1Y−13.2%−15.3%Volatility · 1Y24.2%
SCHD vs VIGYTDSchwabSCHDSA+34.6%vsBVVIGVanguard+16.0%Jan 1Nov 11+34.6%+16.0%+34.6%Year to date+16.0%2.9%Yield1.4%$123BAssets$109B2–0SCHD winsEnd-of-day Nov 11, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA+8.1%vsBJMJEPIJ.P. Morgan+8.6%Jan 1Nov 11+8.1%+8.6%+8.1%Year to date+8.6%12.2%Yield7.8%$41.8BAssets$46.8B1–1levelEnd-of-day Nov 11, 2026
SPYM vs SPYYTDSPDRSPYMSA+12.4%vsBSSPYSPDR+12.3%Jan 1Nov 11+12.4%+12.3%+12.4%Year to date+12.3%1.0%Yield1.0%$183BAssets$793B1–0SPYM winsEnd-of-day Nov 11, 2026
Overlap: CANC, PAVEToday0.0%most shared, CANC and PAVECANCPAVECANC—0.0%PAVE0.0%—End-of-day Nov 11, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$33most kept, PAVEPAVE$80 − $47 = $33CANC$5 − $99 = −$94KeptFeeEnd-of-day Nov 11, 2026 · yield in dollars minus the fee